✦ LIBER ✦

Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections*

✍ Scribed by Khashab, Mohammed M.; Xiang, Jim; Kahn, James B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled clinical trial o

✍ Zhao, Xu; Wu, Ju-fang; Xiu, Qing-yu; Wang, Chen; Zhang, De-ping; Huang, Jian-an; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 401 KB

A trial of levofloxacin 750 mg once dail

✍ Klausner, Howard A.; Brown, Patricia; Peterson, Janet; Kaul, Simrati; Khashab, M 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 363 KB

A Double-Blind, Randomized Comparison of

✍ Janet Peterson; Simrati Kaul; Mohammed Khashab; Alan C. Fisher; James B. Kahn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Clinical evaluation of oral levofloxacin

✍ Ying-yuan Zhang; Hai-hui Huang; Zhen-yi Ren; Hong-guang Zheng; Yun-song Yu; Xiao 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 273 KB

Roxithromycin 150 mg b.i.d. versus amoxy

✍ N. C. Karalus; J. E. Garrett; S. D. R. Lang; R. A. Leng; G. N. Kostalas; R. T. M 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 1024 KB

O142 Once daily, levofloxacin 750 mg for

✍ P. Brown; J. Peterson; M. Khashab; S. Kaul; A. Fisher; J. Kahn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB